Number of the records: 1  

Cotargeting of BCL2 with Venetoclax and MCL1 with S63845 Is Synthetically Lethal In Vivo in Relapsed Mantle Cell Lymphoma

  1. 1.
    SYSNO0521329
    TitleCotargeting of BCL2 with Venetoclax and MCL1 with S63845 Is Synthetically Lethal In Vivo in Relapsed Mantle Cell Lymphoma
    Author(s) Průková, D. (CZ)
    Anděra, Ladislav (BTO-N)
    Nahácka, Zuzana (BTO-N)
    Karolová, J. (CZ)
    Svaton, M. (CZ)
    Klanova, M. (CZ)
    Havranek, O. (CZ)
    Soukup, J. (CZ)
    Svobodová, K. (CZ)
    Zemanová, Z. (CZ)
    Tušková, D. (CZ)
    Pokorná, E. (CZ)
    Helman, K. (CZ)
    Forsterova, K. (CZ)
    Pacheco-Blanco, M. (CZ)
    Vockova, P. (CZ)
    Berková, A. (CZ)
    Froňková, E. (CZ)
    Trněný, M. (CZ)
    Klener, P. (CZ)
    Source Title Clinical Cancer Research. Roč. 25, č. 14 (2019), s. 4455-4465. - : American Association for Cancer Research
    Document TypeČlánek v odborném periodiku
    Institutional supportBTO-N - RVO:86652036
    Languageeng
    CountryUS
    Keywords acute myeloid-leukemia * open-label * cancer * landscape
    URLhttps://clincancerres.aacrjournals.org/content/25/14/4455
    Permanent Linkhttp://hdl.handle.net/11104/0305960
     
Number of the records: 1  

  This site uses cookies to make them easier to browse. Learn more about how we use cookies.